AstraZeneca Annual Report and Form 20-F Information 2011

Corporate GovernanceBoard of Directors andSenior Executive TeamA diverse team with the skills andexperience to lead the businessThis section briefly describes how the Group isorganised, including the overall structure andprincipal roles and responsibilities of the Board,its committees and the SET.Board composition, processes and responsibilitiesThe Board comprises two Executive Directors (the CEO and the CFO)and nine Non-Executive Directors. The membership of the Board at31 December 2011 and information about individual Directors iscontained in the Board of Directors section below and overleaf.All Directors are collectively responsible for the success of the Group.In addition, the Non-Executive Directors are responsible for exercisingindependent, objective judgement in respect of Board decisions andfor scrutinising and challenging management. The Non-ExecutiveDirectors also have various responsibilities concerning the integrityof financial information, internal controls and risk management.Board compositionLength of tenure ofNon-Executive Directors(years)Gender split of DirectorsDirectors’ nationalities2124381253Corporate Governance0–23–56–10>10MaleFemaleFrenchUSUKSwedishAstraZeneca Annual Report and Form 20-F Information 2011Board of Directors and Senior Executive Team 99